 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Current Price	$10.92
Prev Close	$10.61
Open	$10.62
Dividend Yield	0.00%
50-Day Moving Average	$9.45
Beta	1.37
Avg. Volume	179,550.16
PE Ratio	-4.42

52-Week High	$22.87
52-Week Low	$6.88
Market Capitalization	$482.54M
EPS	-$2.47
Price to Book	2.26
Revenue Per Employee	$124,418.80
Enterprise Value/EBITDA	-1.05

STOK Stoke Therapeutics Inc

About

Feed

Fundamentals

News